Jesús Tornero Molina-rekin lankidetzan egindako argitalpenak (10)

2022

  1. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis

    Reumatologia Clinica, Vol. 18, Núm. 1, pp. 33-41

2020

  1. Efficacy and safety of glucocorticoids in rheumatoid arthritis: Systematic literature review

    Reumatologia Clinica, Vol. 16, Núm. 3, pp. 222-228

  2. Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis

    Reumatologia Clinica, Vol. 16, Núm. 4, pp. 272-281

  3. Practical Aspects of Biological Throught Levels and Antidrug Antibodies in Rheumatoid Arthritis and Spondyloarthritis

    Reumatologia Clinica, Vol. 16, Núm. 5, pp. 378-385

2019

  1. Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial

    Arthritis and Rheumatology, Vol. 71, Núm. 10, pp. 1616-1625

2018

  1. Recommendations for the use of parenteral methotrexate in rheumatic diseases

    Reumatologia Clinica, Vol. 14, Núm. 3, pp. 142-149

  2. Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review

    Rheumatology International, Vol. 38, Núm. 6, pp. 975-983

2017

  1. Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis

    Arthritis Care and Research, Vol. 69, Núm. 1, pp. 150-155

2015

  1. Recomendaciones para el uso del metotrexato en artritis reumatoide: Incremento y reducción de dosis y vías de administración

    Reumatologia Clinica, Vol. 11, Núm. 1, pp. 3-8

2006

  1. Consensus document of the Spanish Society of Rheumatology on the use of opioids in the treatment of rheumatic pain

    Reumatologia Clinica, Vol. 2, Núm. SPEC. ISS. 1, pp. 50-54